Introduction {#sec1}
============

Benzotriazole methodology has been emerged as an efficient, economical, and quick way for common organic transformations during the last four decades.^[@ref1]^ The benzotriazole ring cleavage (BtRC) approach proficiently assists the development of a wide spectrum of benzoheterocycles via either Dimroth rearrangement, reagent-supported ring opening, free radical path, photolysis, or thermolysis.^[@ref2]−[@ref6]^ Because of benzoxazole being one of the most fascinating moieties having an extensive range of biological, pharmaceutical, industrial, and analytical importance,^[@ref7]^ we intended to explore our standard protocols of benzotriazole methodology for the synthesis of benzoxazole derivatives. Influenced by our previously reported benzothiazole synthesis,^[@ref2]^ which followed free radical mechanism of BtRC, we applied a similar protocol using tributyltin hydride for ring cleavage of *N*-phenylacylbenzotriazole. However, the reaction resulted in *N*-phenylbenzamide^[@ref8]^ instead of 2-phenyl benzoxazole. Then, we switched our tryout from free-radical reagents to Lewis acid reagents and finally became successful when we refluxed *N*-phenyl benzotriazole with anhydrous AlCl~3~ in dry toluene ([Scheme [1](#sch1){ref-type="scheme"}](#sch1){ref-type="scheme"}).

![Comparison of Benzotriazole Ring Cleavage (BtRC) Processes](ao-2017-009652_0002){#sch1}

Results and Discussion {#sec2}
======================

Our synthetic strategy was initiated with the formation of *N*-acylbenzotriazoles (**2**) from corresponding carboxylic acids (**1**) following two standard protocols, i.e., either by reaction with thionyl chloride and 1*H*-benzotriazole or by treatment with PPh~3~/NBS and 1*H*-benzotriazole.^[@cit4e],[@ref9]^ The resulting *N*-acylbenzotriazoles (**2**) were subjected to ring cleavage by employing 1 equiv of anhydrous AlCl~3~ at 140 °C, which resulted in benzoxazole derivative **3** ([Scheme [2](#sch2){ref-type="scheme"}](#sch2){ref-type="scheme"}).

![Synthesis of Benzoxazole Derivative **3** from Corresponding *N*-Acylbenzotriazoles **2** through Cleavage of Benzotriazole Ring](ao-2017-009652_0006){#sch2}

For the reaction optimization study, a sequence of reactions were carried out with compound **2a**, in the presence of different Lewis acids in various solvents at diverse ranges of temperature to afford benzoxazole **3a** ([Table [1](#tbl1){ref-type="other"}](#tbl1){ref-type="other"}).

###### Optimization with (1*H*-Benzo\[*d*\]\[1,2,3\]triazol-1-yl)(phenyl)methanone

![](ao-2017-009652_0005){#fx1}

  entry[a](#t1fn1){ref-type="table-fn"}   reagent   amount (equiv)   time (h)   solvent   temp (°C)   yield[b](#t1fn2){ref-type="table-fn"} (%)
  --------------------------------------- --------- ---------------- ---------- --------- ----------- -------------------------------------------
  1                                       AlCl~3~   0.5              1          toluene   140         47
  2                                       AlCl~3~   0                4          toluene   140         0
  3                                       AlCl~3~   1                2          toluene   140         61
  4                                       AlCl~3~   1.2              2          toluene   140         65
  5                                       AlCl~3~   1.2              4          toluene   90          0
  6                                       AlCl~3~   1.2              4          toluene   110         0
  7                                       AlCl~3~   1.2              2          toluene   130         59
  8                                       AlCl~3~   1.2              2          toluene   150         63
  9                                       AlCl~3~   1.2              2          MeCN      45          0
  10                                      AlCl~3~   1.2              2          DMF       140         0
  11                                      AlCl~3~   1.2              2          DCM       45          0
  12                                      AlCl~3~   1.2              2          THF       45          0
  13                                      AlCl~3~   1.2              2          benzene   140         43
  14                                      ZnCl~2~   1.2              2          toluene   100         0
  15                                      ZnCl~2~   1.2              2          toluene   140         15
  16                                      CuCl~2~   1.2              2          toluene   140         0
  17                                      HgCl~2~   1.2              2          toluene   140         0
  18                                      FeCl~3~   1.2              2          toluene   140         53

Reaction carried out at a higher temperature in a sealed tube under argon.

Yields reported after column chromatography (SiO~2~).

Best results were achieved with high-boiling-point, aprotic nonpolar solvents, such as toluene and benzene. The optimum temperature for the reaction was found to be 140 °C, and below 130 °C, the reaction does not proceed at all. A total of 1.2 equiv of dry toluene under inert atmospheric conditions yielded the maximum product (65%) in 2 h. Among the various substrates, aryl-group-containing *N*-acylbenzotriazoles afforded benzoxazoles ([Table [2](#tbl2){ref-type="other"}](#tbl2){ref-type="other"}), whereas alkyl-containing *N*-acylbenzotriazoles underwent traditional Friedel--Crafts acylation.

###### Synthesis of Benzoxazole Derivative **3a−s** from Corresponding *N*-Acylbenzotriazoles **2a−s**[a](#t2fn1){ref-type="table-fn"}^,^[b](#t2fn2){ref-type="table-fn"}

![](ao-2017-009652_0001){#fx2}

Molar ratios: anhydrous AlCl~3~ (1.2 equiv); yield reported after purification by column chromatography (SiO~2~).

Yield of demethylated product **3h**.

No specific variation of yield was found with the electron-withdrawing- or electron-donor-group substitution on the aryl ring. The substrate containing iodo substituent at ortho postion **2q** did not give any product, and the starting compound was recovered after column chromatography (SiO~2~). *o*-Methoxy-substituted substrate **2f** underwent demethylation and formed compound **3h** (91%); however, the *m*-methoxy group did not give such type of product, and target benzoxazole was isolated in good yield. The optimized protocol successfully transformed various acylbenzotriazoles **2a--s** to their respective benzoxazoles **3a--s** in good to excellent yields ranging from 43 to 91% ([Table [2](#tbl2){ref-type="other"}](#tbl2){ref-type="other"}). However, when we carried out this reaction with benzylic *N*-acylbenzotriazoles, we obtained corresponding ketones in excellent yield, which suggests that the reaction followed the traditional Friedel--Crafts path with alkyl substrates ([Scheme [3](#sch3){ref-type="scheme"}](#sch3){ref-type="scheme"}).

![Formation of the Ketone Product from the Corresponding Benzylic *N*-Acylbenzotriazole via the Traditional Friedel--Crafts Reaction](ao-2017-009652_0008){#sch3}

BtRC-Mediated Cyclization Reaction on a Gram Scale {#sec2.1}
--------------------------------------------------

With the aim of performing quantity-based generalization of the reaction, we carried out the reaction with a larger quantity of starting materials. Scaling up the quantity from a milligram to a gram scale did not affect the course and yield of reaction, and the yields were found to be 64% and 81% for **3a** and **3k**, respectively ([Scheme [4](#sch4){ref-type="scheme"}](#sch4){ref-type="scheme"}).

![Synthesis of Benzoxazole Derivatives **3a** and **3n** on a Gram Scale via the BtRC Approach](ao-2017-009652_0003){#sch4}

The importance of developed benzoxazoles may be visualized in terms of its presence as a structural core in a diverse range of natural and synthetic molecules, for example, antimycobacterial agents pseudopteroxazole, UK-1, and AJI9561; HIV reverse transcriptase inhibitor L-697,661; estrogen receptor-β agonist ERB-041; selective peroxisome proliferator-activated receptor γ antagonist JTP-426467; anticancer agent NSC-693638; and also Tafamidis meglumine, a transthyretin amyloid inhibitor (developed by SCRIPPS/Pfizer in 2014) marketed for the treatment of neorodegenerative disorder.^[@ref7],[@ref10]^

Mechanistic Consideration {#sec2.2}
-------------------------

A plausible mechanism of the reaction is shown in [Scheme [5](#sch5){ref-type="scheme"}](#sch5){ref-type="scheme"}, where AlCl~3~ initiates the process by a rapid reaction with *N*-acylbenzotriazole to form intermediate **A**. This can give the traditional Friedel--Crafts product, which is generally obtained in the case of aliphatic *N*-acylbenzotriazoles, but in the case of aryl *N*-acylbenzotriazole, intermediate **A** favors cyclization via formation of carbocation complex intermediates **B** and **C** with the loss of molecular nitrogen (N~2~). The extended π-conjugative interactions involved in the carbocation system develop its stability and make the system stable enough to give the cyclized oxazole product. The stabilization of intermediate **C** could be governed via the delocalization of positive charge over the aryl ring and carbonyl functionality ([Scheme [5](#sch5){ref-type="scheme"}](#sch5){ref-type="scheme"}).

![Proposed Mechanism for Benzotriazole Ring Cleavage under Ionic Conditions Using Anhydrous AlCl~3~](ao-2017-009652_0004){#sch5}

Conclusions {#sec3}
===========

In summary, we introduced a convenient one-step synthetic route to convert *N*-acylbenzotriazole to benzoxazole via benzotriazole ring cleavage (BtRC). The reaction was best assisted by AlCl~3~ and possibly followed a ionic mechanism. The synthetic path showed equal compatibility with both electron-withdrawing and electron-donating substituents on the aromatic ring as well as with the quantity on a milligram or a gram scale.

Experimental Section {#sec4}
====================

General Remarks {#sec4.1}
---------------

All of the reactions were performed under an argon atmosphere in anhydrous solvents. Glasswares were dried in oven at 100 °C, 1 h prior to use. All reagents and solvents were of pure analytical grade. Thin layer chromatography (TLC) was carried out using 60 F~254~ silica gel-precoated aluminum plates, and visualization was under a UV lamp (λ~max~ = 254 nm). ^1^H and ^13^C NMR spectra were recorded in CDCl~3~ solvent at 300 or 500 MHz and 75 or 125 MHz, respectively. Chemical shifts are reported in parts per million downfield from TMS as an internal standard; *J* values are reported in hertz. Mass spectra were recorded using electrospray ionization mass spectrometry (ESI-MS). IR spectra were recorded as Nujol mulls in KBr pellets. Elemental analysis was performed by a C, H, N analyzer with the results within ±0.4% of the calculated values.

Procedure for the Synthesis of Arylcarbonylbenzotriazoles (RCOBt, **2a**, **2c--2s**) and Their Characterization Data {#sec4.2}
---------------------------------------------------------------------------------------------------------------------

To a solution of carboxylic acid (**1a**, 7.34 mmol) in anhydrous dichloromethane (100 mL), thionyl chloride (8.27 mmol) was added at room temperature and stirred for 15 min. 1*H*-1,2,3-Benzotriazole (25.69 mmol) was then added to this mixture portionwise, and the resulting mixture was stirred for 2--3 h at room temperature. The completion of the reaction was monitored by TLC, and the reaction mass was washed with 10% Na~2~CO~3~ solution, followed by water and brine solution. The organic layer was separated, dried over anhydrous Na~2~SO~4~, and concentrated under reduced pressure. The crude was purified by flash column chromatography using ethyl acetate and *n*-hexane to afford pure products **2a**.

Procedure for the Synthesis of Arylcarbonylbenzotriazole (**2b**) {#sec4.3}
-----------------------------------------------------------------

To a stirring solution of PPh~3~ (1.1 g, 4.41 mmol) and NBS (0.78 g, 4.41 mmol) in anhydrous dichloromethane (25 mL), compound **1b** (0.5 g, 3.67 mmol) was added at 0 °C and stirred for 15 min. To this mixture, 1*H*-benzotriazole (0.5 g, 4.2 mmol) was added portionwise, and the mixture was allowed to stir at room temperature for 1 h. The completion of the reaction was monitored by TLC, and the reaction mass was concentrated under reduced pressure till dry. The crude was purified by flash column chromatography using gradient mixtures of ethyl acetate and *n*-hexane to afford pure product **2b** (0.84 g, 3.56 mmol).

### (1*H*-Benzo\[*d*\]\[1,2,3\]triazol-1-yl)(phenyl)methanone (**2a**)^[@ref11]^ {#sec4.3.1}

White crystalline solid, yield 95%; 1.55 g, *R*~*f*~ = 0.6 (10% ethyl acetate/*n*-hexane); mp = 112--113 °C; lit., mp 110--112 °C, MS: *m*/*z* 224 \[M + H\]; ^1^H NMR (300 MHz, CDCl~3~): δ 8.35 (d, *J* = 8.5 Hz, 1H), 8.20 (d, *J* = 7.5 Hz, 2H), 8.14 (d, *J* = 8.0 Hz, 1H), 7.68--7.65 (m, 2H), 7.56--7.49 (m, 3H); ^13^C NMR (75 MHz, CDCl~3~): δ 166.7, 145.7, 133.7, 132.3, 131.8, 131.5, 130.4, 128.5, 126.4, 120.2, and 114.8 ppm.

### (1*H*-Benzo\[*d*\]\[1,2,3\]triazol-1-yl)(*p*-tolyl)methanone (**2b**)^[@ref11]^ {#sec4.3.2}

White crystalline solid, yield 97%; 0.84 g, *R*~*f*~ = 0.7 (10% ethyl acetate/*n*-hexane); mp = 123--124 °C; lit., mp 122--124 °C MS: *m*/*z* 238 \[M + H\]^+^; ^1^H NMR (300 MHz, CDCl~3~): δ 8.31 (d, *J* = 8.5 Hz, 1H), 8.10--8.08 (m, 3H), 7.63--7.60 (m, 1H), 7.46 (t, *J* = 7.5 Hz, 1H), 7.32 (d, *J* = 7.5 Hz, 2H), 2.42 (s, 3H); ^13^C NMR (75 MHz, CDCl~3~): δ 166.5, 145.7, 144.8, 132.4, 132.0 (2C), 130.2, 129.2 (2C), 128.6, 126.2, 120.1, 114.8, and 21.8 ppm.

### (1*H*-Benzo\[*d*\]\[1,2,3\]triazol-1-yl)(*m*-tolyl)methanone (**2c**)^[@ref11]^ {#sec4.3.3}

White crystalline solid, yield 83%; 1.44 g, *R*~*f*~ = 0.8 (10% ethyl acetate/*n*-hexane); mp = 75--76 °C; lit., mp 77--79 °C MS: *m*/*z* 238 \[M + H\]^+^; ^1^H NMR (300 MHz, CDCl~3~): δ 8.31 (d, *J* = 8.5 Hz, 1H), 8.10 (d, *J* = 7.5 Hz, 1H), 7.96 (bs, 2H), 7.62 (t, *J* = 7.5 Hz, 1H), 7.49--7.40 (m, 3H), 2.41 (s, 3H); ^13^C NMR (75 MHz, CDCl~3~): δ 166.9, 145.7, 138.3, 134.5, 132.4, 132.1, 131.4, 130.3, 129.0, 128.3, 126.3, 120.1, 114.8, and 21.4 ppm.

### (1*H*-Benzo\[*d*\]\[1,2,3\]triazol-1-yl)(*o*-tolyl)methanone (**2d**)^[@ref11]^ {#sec4.3.4}

White crystalline solid, yield 74%; 1.28 g, *R*~*f*~ = 0.8 (10% ethyl acetate/*n*-hexane); mp = 110--111 °C; lit., mp 110--111 °C MS: *m*/*z* 238 \[M + H\]^+^; ^1^H NMR (300 MHz, CDCl~3~): δ 8.27 (d, *J* = 8.5 Hz, 1H), 8.02 (d, *J* = 7.5 Hz, 1H), 7.58--7.55 (m, 1H), 7.51 (d, *J* = 6.5 Hz, 1H), 7.42--7.36 (m, 2H), 7.24--7.20 (m, 2H), 2.31 (s, 3H); ^13^C NMR (75 MHz, CDCl~3~): δ 168.1, 145.9, 137.8, 132.1, 131.7, 131.5, 130.9, 130.2, 129.9, 126.2, 125.3, 120.1, 114.4, and 19.9 ppm.

### (1*H*-Benzo\[*d*\]\[1,2,3\]triazol-1-yl)(3-methoxyphenyl)methanone (**2e**)^[@cit4f]^ {#sec4.3.5}

White crystalline solid, yield 72%; 1.34 g, *R*~*f*~ = 0.7 (10% ethyl acetate/*n*-hexane); mp = 80--84 °C; MS: *m*/*z* 254 \[M + H\]^+^; ^1^H NMR (300 MHz, CDCl~3~): δ 8.35 (d, *J* = 7.5 Hz, 1H), 8.14 (d, *J* = 7.5 Hz, 1H), 7.79 (d, *J* = 7.5 Hz, 1H), 7.70--7.66 (m, 2H), 7.53--7.50 (m, 1H), 7.47--7.24 (m, 1H), 7.21--7.19 (m, 1H), 3.87 (s, 3H); ^13^C NMR (75 MHz, CDCl~3~): δ 166.6, 159.5, 145.8, 132.6, 132.4, 130.4, 129.5, 126.4, 124.3, 120.3, 120.2, 116.2, 114.8, and 55.6 ppm.

### (1*H*-Benzo\[*d*\]\[1,2,3\]triazol-1-yl)(2-methoxyphenyl)methanone (**2f**)^[@ref11]^ {#sec4.3.6}

Colorless solid, yield 89%; 1.65 g, *R*~*f*~ = 0.6 (10% ethyl acetate/*n*-hexane); mp = 95--96 °C; lit., mp 96--97 °C MS: *m*/*z* 254 \[M + H\]^+^; ^1^H NMR (300 MHz, CDCl~3~): ^1^H NMR (300 MHz, CDCl~3~): δ 8.32 (d, *J* = 8.5 Hz, 1H), 8.05 (d, *J* = 7.5 Hz, 1H), 7.61--7.56 (m, 2H), 7.50--7.42 (m, 2H), 7.05--6.98 (m, 2H), 3.68 (s, 3H); ^13^C NMR (75 MHz, CDCl~3~): δ 166.9, 157.9, 146.1, 133.6, 131.5, 130.4, 130.3, 126.2, 122.8, 120.5, 120.1, 114.4, 111.8, and 55.8 ppm.

### (1*H*-Benzo\[*d*\]\[1,2,3\]triazol-1-yl)(3-(trifluoromethyl)phenyl)methanone (**2i**)^[@cit4f]^ {#sec4.3.7}

White crystalline solid, yield 53%; 1.13 g, *R*~*f*~ = 0.7 (10% ethyl acetate/*n*-hexane); mp = 52--53 °C; lit., mp 52--54 °C MS: *m*/*z* 292 \[M + H\]^+^; ^1^H NMR (500 MHz, CDCl~3~): δ 8.47 (s, 1H), 8.42 (d, *J* = 7.5 Hz, 1H), 8.37 (d, *J* = 8.5 Hz, 1H), 8.16 (d, *J* = 8.5, 1H), 7.93 (d, *J* = 7.5 Hz, 1H), 7.72--7.69 (m, 2H), 7.55 (t, *J* = 7.5 Hz, 1H); ^13^C NMR (125 MHz, CDCl~3~): δ 165.4, 145.8, 134.9, 132.3, 132.2, 130.8, 130.2, 130.1, 129.1, 128.7, 128.6, 126.7, 120.4, and 114.8 ppm.

### (1*H*-Benzo\[*d*\]\[1,2,3\]triazol-1-yl)(3-fluorophenyl)methanone (**2j**)^[@cit4c]^ {#sec4.3.8}

White crystalline solid, yield 71%; 1.26 g, *R*~*f*~ = 0.6 (10% ethyl acetate/*n*-hexane); mp = 102--103 °C; lit., mp 102 °C MS: *m*/*z* 242 \[M + H\]^+^; ^1^H NMR (500 MHz, CDCl~3~): δ 8.34 (d, *J* = 8.5 Hz, 1H), 8.14 (d, *J* = 8.5 Hz, 1H), 8.03 (d, *J* = 7.5 Hz, 1H), 7.93 (d, *J* = 9.5 Hz, 1H), 7.68 (t, *J* = 7.5 Hz, 1H), 7.54 (dd, *J* = 7.5, 7.0 Hz, 2H), 7.38 (t, *J* = 7.5 Hz, 1H); ^13^C NMR (125 MHz, CDCl~3~): δ 165.3, 162.2 (d, *J* = 237.5 Hz), 145.7, 133.2 (d, *J* = 8.4 Hz), 132.2, 130.6, 130.1 (d, *J* = 8.4 Hz), 127.6 (d, *J* = 4.0 Hz), 126.5, 120.8 (d, *J* = 20 Hz), 120.3, 118.6 (d, *J* = 24 Hz), and 114.7 ppm.

### (1*H*-Benzo\[*d*\]\[1,2,3\]triazol-1-yl)(4-chlorophenyl)methanone (**2l**)^[@ref11]^ {#sec4.3.9}

White crystalline solid, yield 71%; 1.34 g, *R*~*f*~ = 0.5 (10% ethyl acetate/*n*-hexane); mp = 137--138 °C; lit., mp 138 °C MS: *m*/*z* 258 \[M + H\]^+^; ^1^H NMR (300 MHz, CDCl~3~): δ 8.30 (d, *J* = 8.5 Hz, 1H), 8.13--8.08 (m, 3H), 7.63 (t, *J* = 7.5 Hz, 1H), 7.49--7.46 (m, 3H); ^13^C NMR (75 MHz, CDCl~3~): δ 165.6, 145.8, 140.5, 133.2 (2C), 132.3, 130.6, 129.8, 128.9 (2C), 126.6, 120.3, and 114.8 ppm.

### (1*H*-Benzo\[*d*\]\[1,2,3\]triazol-1-yl)(3-chlorophenyl)methanone (**2m**)^[@ref11]^ {#sec4.3.10}

White crystalline solid, yield 64%; 1.20 g, *R*~*f*~ = 0.5 (10% ethyl acetate/*n*-hexane); mp = 122--124 °C; lit., mp 120--121 °C MS: *m*/*z* 258 \[M + H\]^+^; ^1^H NMR (300 MHz, CDCl~3~): δ 8.31 (d, *J* = 8.5 Hz, 1H), 8.15--8.06 (m, 3H), 7.67--7.60 (m, 2H), 7.52--7.45 (m, 2H); ^13^C NMR (75 MHz, CDCl~3~): δ 165.3, 145.7, 134.6, 133.7, 133.1, 132.2, 131.6, 130.6, 129.9, 129.7, 126.6, 120.3, and 114.8.

### (1*H*-Benzo\[*d*\]\[1,2,3\]triazol-1-yl)(2-chlorophenyl)methanone (**2n**)^[@ref11]^ {#sec4.3.11}

White crystalline solid, yield 81%; 1.53g, *R*~*f*~ = 0.5 (15% ethyl acetate/*n*-hexane); mp = 81--83 °C; lit., mp 82--84 °C MS: *m*/*z* 258 \[M + H\]^+^; ^1^H NMR (300 MHz, CDCl~3~): δ 8.35 (d, *J* = 8.5 Hz, 1H), 8.09 (d, *J* = 7.5 Hz, 1H), 7.68--7.62 (m, 2H), 7.51--7.48 (m, 3H), 7.41--7.38 (m, 1H); ^13^C NMR (75 MHz, CDCl~3~): δ 165.8, 146.2, 132.9, 132.7, 132.3, 131.3, 130.8, 130.2 (2C), 126.8, 126.7, 120.4, and 114.4 ppm.

### (1*H*-Benzo\[*d*\]\[1,2,3\]triazol-1-yl)(4-bromophenyl)methanone (**2p**)^[@cit4g]^ {#sec4.3.12}

Light yellow solid, yield 83%; 1.83 g, *R*~*f*~ = 0.5 (10% ethyl acetate/*n*-hexane); mp = 130--132 °C; lit., mp 142--145 °C MS: *m*/*z* 302 \[M + H\]^+^; ^1^H NMR (300 MHz, CDCl~3~): δ 8.23 (d, *J* = 8.5 Hz, 1H), 8.04 (d, *J* = 8.0 Hz, 1H), 8.00--7.97 (m, 2H), 7.60--7.56 (m, 3H), 7.44--7.41 (m, 1H); ^13^C NMR (75 MHz, CDCl~3~): δ 165.5, 145.5, 133.0 (2C), 132.0, 131.6 (2C), 130.4, 130.0, 129.0, 126.4, 120.1, and 114.6 ppm.

### (1*H*-Benzo\[*d*\]\[1,2,3\]triazol-1-yl)(2-bromophenyl)methanone (**2r**)^[@ref12],[@ref13]^ {#sec4.3.13}

Solid, *R*~*f*~ = 0.7 (5% ethyl acetate/*n*-hexane); MS: *m*/*z* 302 \[M + H\]^+^; ^1^H NMR (300 MHz, CDCl~3~): δ 8.35 (d, *J* = 8.4 Hz, 1H), 8.10 (d, *J* = 8.1 Hz, 1H), 7.70--7.60 (m, 3H), 7.53--7.38 (m, 3H); ^13^C NMR (75 MHz, CDCl~3~): δ 166.0, 145.8, 134.7, 132.9, 132.3, 130.9, 130.4, 129.8, 127.0, 126.4, 120.2, 120.0, and 114.0 ppm.

### (1*H*-Benzo\[*d*\]\[1,2,3\]triazol-1-yl)(3-bromophenyl)methanone (**2s**)^[@ref14]^ {#sec4.3.14}

Solid, yield 87%; 1.92 g, *R*~*f*~ = 0.7 (5% ethyl acetate/*n*-hexane); MS: *m*/*z* 302 \[M + H\]^+^; ^1^H NMR (300 MHz, CDCl~3~): δ 8.37(d, *J* = 9.0 Hz, 2H), 8.17 (d, *J* = 8.4 Hz, 2H), 7.81 (d, *J* = 8.1 Hz, 1H), 7.71 (t, *J* = 7.5 Hz, 1H), 7.58--7.53 (m, 1H), 7.45 (d, *J* = 7.8 Hz, 1H); anal. calcd for C~13~H~8~BrN~3~O: C, 51.68; H, 2.67; N, 13.91. Found: C, 51.47; H, 2.71; N, 13.84.

Procedure for the Synthesis of Benzoxazoles and Their Characterization Data {#sec4.4}
---------------------------------------------------------------------------

A stirring solution of compound **2b** (0.8 mmol) in toluene was added with AlCl~3~ (1 mmol) under an inert atmosphere. The reaction was stirred under heating at 140 °C. After the completion of the reaction (monitored by TLC), the reaction mixture was concentrated in vacuo and extracted with CH~2~Cl~2~, water, and brine solutions. After drying over anhydrous Na~2~SO~4~, the organic layer was concentrated in vacuo. Purification using flash column chromatography afforded the benzoxazole derivative.

### 2-Phenyl benzo\[*d*\]oxazole (**3a**)^[@ref15]^ {#sec4.4.1}

Crystalline solid, yield 65%; 0.101 g, *R*~*f*~ = 0.6 (2% ethyl acetate/*n*-hexane); mp = 103--104 °C; lit., mp 102--104 °C MS: *m*/*z* 196 \[M + H\]^+^; ^1^H NMR (300 MHz, CDCl~3~): δ 8.26 (dd, *J* = 3.9, 2.1 Hz, 2H), 7.79--7.76 (m, 1H), 7.60--7.53 (m, 4H), 7.35 (dd, *J* = 3.3,2.4 Hz, 2H); ^13^C NMR (75 MHz, CDCl~3~): δ 163.0, 150.7, 142.0, 131.5, 128.8(2C), 127.5(2C), 127.1, 125.0, 124.5, 119.9, and 110.5 ppm.

### 2-(*p*-Tolyl)benzo\[*d*\]oxazole (**3b**)^[@ref15]^ {#sec4.4.2}

White solid, yield 59%; 0.98 g, *R*~*f*~ = 0.6 (2% ethyl acetate/*n*-hexane); mp = 116--118 °C; lit., mp 116--117 °C MS: *m*/*z* 210 \[M + H\]^+^; ^1^H NMR (300 MHz, CDCl~3~): δ 8.12 (d, *J* = 8.1 Hz, 2H), 7.76--7.73 (m,1H), 7.55--7.52 (m, 1H), 7.32--7.27 (m, 4H), 2.40 (s, 3H); ^13^C NMR (75 MHz, CDCl~3~): δ 163.2, 150.7, 142.2, 142.0, 129.6 (2C), 127.5 (2C), 124.8, 124.4, 124.4, 119.8, 110.4, and 21.6 ppm.

### 2-(*m*-Tolyl)benzo\[*d*\]oxazole (**3c**)^[@ref15]^ {#sec4.4.3}

Crystalline solid, yield 61%; 0.102 g, *R*~*f*~ = 0.7 (2% ethyl acetate/*n*-hexane); mp = 84--86 °C; lit., mp 82--83 °C MS: *m*/*z* 210 \[M + H\]^+^; ^1^H NMR (300 MHz, CDCl~3~): δ 8.00--7.94 (m, 2H), 7.68 (bs, 1H), 7.47 (bs, 1H), 7.33--7.16 (m, 4H), 2.35 (s, 3H); ^13^C NMR (75 MHz, CDCl~3~): δ 163.2, 150.7, 142.1, 138.6, 132.3, 128.7, 128.1, 127.0, 124.9, 124.7, 124.4, 119.8, 110.5, and 21.2 ppm.

### 2-(*o*-Tolyl)benzo\[*d*\]oxazole (**3d**)^[@ref15]^ {#sec4.4.4}

Crystalline solid, yield 60%; 0.100 g, *R*~*f*~ = 0.7 (2% ethyl acetate/*n*-hexane); mp = 67--68 °C; lit., mp 67 °C MS: *m*/*z* 210 \[M + H\]^+^; ^1^H NMR (300 MHz, CDCl~3~): δ 8.16 (d, *J* = 7.5 Hz, 1H), 7.80--7.77 (m, 1H), 7.58--7.55 (dd, *J* = 3.3, 2.7 Hz, 1H), 7.41--7.26 (m, 5H), 2.80 (s, 3H); ^13^C NMR (75 MHz, CDCl~3~): δ 163.3, 150.2, 142.1, 138.8, 131.7, 130.8, 129.8, 126.2, 125.9, 124.9, 124.3, 120.1, 110.4, and 22.1 ppm.

### 2-(3-Methoxyphenyl)benzo\[*d*\]oxazole (**3e**)^[@ref16]^ {#sec4.4.5}

Solid, yield 57%; 0.103 g, *R*~*f*~ = 0.6 (2% ethyl acetate/*n*-hexane); mp = 72--74 °C; lit., mp 71--75 °C MS: *m*/*z* 226 \[M + H\]^+^; ^1^H NMR (300 MHz, CDCl~3~): δ 7.85 (d, *J* = 7.8 Hz, 1H), 7.79--7.76 (m, 2H), 7.59 (dd, *J* = 3.3, 2.7 Hz, 1H), 7.42 (t, *J* = 7.8, 1H), 7.37--7.32 (m, 2H), 7.10--7.06 (m,1H), 3.91 (s, 3H); ^13^C NMR (75 MHz, CDCl~3~): δ 161.9, 158.9, 149.7, 141.0, 128.9, 127.3, 124.1, 123.5, 119.1, 119.0, 117.3, 110.9, 109.5, and 54.5 ppm.

### 2-(3-Phenoxyphenyl)benzo\[*d*\]oxazole (**3g**)^[@ref17]^ {#sec4.4.6}

Colorless crystalline solid, yield 43%; 0.098 g, *R*~*f*~ = 0.6 (3% ethyl acetate/*n*-hexane); mp = 86--88 °C; lit., mp 84--86 °C MS: *m*/*z* 288 \[M + H\]^+1^H NMR (300 MHz, CDCl~3~): δ 7.97 (d, *J* = 7.8 Hz, 1H), 7.88 (s, 1H), 7.75--7.72 (m, 1H), 7.53--7.41 (m, 2H), 7.37--7.29 (m, 4H), 7.14--7.10 (m, 2H), 7.07--7.04 (m, 2H); ^13^C NMR (75 MHz, CDCl~3~): δ 162.3, 157.8, 156.7, 150.7, 141.9, 130.3, 129.8(2C), 128.7, 125.2, 124.5, 123.7, 122.3, 121.8, 120.0, 119.1(2C), 117.5, and 110.6 ppm.

### 2-(Benzo\[*d*\]oxazol-2-yl)phenol (**3h**)^[@ref18]^ {#sec4.4.7}

Crystalline solid, yield 73%; 0.123 g, *R*~*f*~ = 0.5 (2% ethyl acetate/*n*-hexane); mp = 122--124 °C; lit., mp 123.5 °C MS: *m*/*z* 212 \[M + H\]^+^; ^1^H NMR (300 MHz, CDCl~3~): δ 11.4 (s, 1H), 7.95 (d, *J* = 6.9 Hz,1H), 7.67--7.64 (m, 1H), 7.54--7.51 (m, 1H), 7.40--7.29 (m, 3H), 7.08 (d, *J* = 7.1 Hz, 1H), 6.95 (t, *J* = 7.5 Hz, 1H); ^13^C NMR (75 MHz, CDCl~3~): δ 162.7, 158.6, 148.9, 139.8, 133.4, 127.0, 125.2, 124.8, 119.4, 119.1, 117.2, 110.5, and 110.4 ppm.

### 2-(3-(Trifluoromethyl)phenyl)benzo\[*d*\]oxazole (**3i**)^[@ref19]^ {#sec4.4.8}

Crystalline solid, yield 67%; 0.14 g, *R*~*f*~ = 0.5 (3% ethyl acetate/*n*-hexane); mp = 119--122 °C; lit., mp 119--120 °C MS: *m*/*z* 264 \[M + H\]^+1^H NMR (300 MHz, CDCl~3~): δ 8.52 (s, 1H), 8.42 (d, *J* = 7.8 Hz,1H), 7.78--7.76 (m, 2H), 7.67--7.58 (m, 2H), 7.39--7.36 (m, 2H); ^13^C NMR (75 MHz, CDCl~3~): δ 161.4, 150.8, 141.8, 131.4, 130.5, 129.5, 128.0, 127.9, 125.7, 124.9, 124.5, 120.3, and 110.7; ^19^F NMR (470 MHz, CDCl~3~): −62.77 ppm.

### 2-(3-Fluorophenyl)benzo\[*d*\]oxazole (**3j**)^[@ref16]^ {#sec4.4.9}

White solid, yield 69%; 0.117 g, *R*~*f*~ = 0.6 (3% ethyl acetate/*n*-hexane); mp = 92--94 °C; lit., mp 92--94 °C MS: *m*/*z* 214 \[M + H\]^+^; ^1^H NMR (500 MHz, CDCl~3~): δ 8.05 (d, *J* = 8.5 Hz, 1H), 7.96--7.93 (m, 1H), 7.79--7.75 (m, 1H), 7.60--7.58 (m, 1H), 7.52--7.47 (m, 1H), 7.39--7.36 (m, 2H), 7.25--7.21 (m, 1H); ^13^C NMR (75 MHz, CDCl~3~): δ 163.9, 162.0, 161.8, 150.8, 142.0, 130.7, 130.6, 129.3, 129.2, 125.6, 124.8, 123.4, 123.3, 120.3, 118.6, 118.5, 114.7, 114.4, 110.7; ^19^F NMR (470 MHz, CDCl~3~): −111.6 ppm.

### 2-(3,5-Difluorophenyl)benzo\[*d*\]oxazole (**3k**)^[@ref20]^ {#sec4.4.10}

Yellow solid, yield 83%; 0.153 g*, R*~*f*~ = 0.6 (4% ethyl acetate/*n*-hexane); MS: *m*/*z* 232 \[M + H\]^+1^H NMR (300 MHz, CDCl~3~): δ 7.64--7.62 (m, 3H), 7.50--7.46 (m,1H), 7.32--7.28 (m, 2H), 6.90--6.84 (m, 1H); ^13^C NMR (75 MHz, CDCl~3~): δ 164.9, 164.7, 161.6, 161.4, 160.7, 150.7, 141.7, 130.1, 129.9, 129.2, 125.8, 124.9, 120.4, 110.4 (m), 106.7 (m); ^19^F NMR (470 MHz, CDCl~3~): −107.9 ppm.

### 2-(4-Chlorophenyl)benzo\[*d*\]oxazole (**3l**)^[@ref15]^ {#sec4.4.11}

Colorless crystal solid, yield 67%; 0.122 g *R*~*f*~ = 0.6 (2% ethyl acetate/*n*-hexane); mp = 150--151 °C; lit., mp 150 °C MS: *m*/*z* 230 \[M + H\]^+^; ^1^H NMR (300 MHz, CDCl~3~): δ 8.16 (d, *J* = 8.4 Hz, 2H), 7.76--7.73 (m, 1H), 7.57--7.54 (m, 1H), 7.47 (d, *J* = 8.4 Hz, 2H), 7.37--7.33 (m, 2H); ^13^C NMR (75 MHz, CDCl~3~): δ 162.0, 150.6, 141.9, 137.7, 129.2(2C), 128.7(2C), 125.6, 125.3, 124.7, 120.0, and 110.5 ppm.

### 2-(3-Chlorophenyl)benzo\[*d*\]oxazole (**3m**)^[@ref16]^ {#sec4.4.12}

Crystal solid, yield 57%; 0.104 g, *R*~*f*~ = 0.7 (3% ethyl acetate/*n*-hexane); mp = 122--124 °C; lit., mp 124--125 °C MS: *m*/*z* 230 \[M + H\]^+^; ^1^H NMR (500 MHz, CDCl~3~): δ 8.21 (s, 1H), 8.09 (d, *J* = 7.0 Hz, 1H), 7.76--7.74 (m, 1H), 7.56--7.54 (m, 1H), 7.47--7.35 (m, 2H), 7.34--7.33 (m, 2H); ^13^C NMR (125 MHz, CDCl~3~): δ 161.6, 150.8, 141.9, 135.1, 131.5, 130.2, 128.9, 127.6, 125.7, 125.6, 124.8, 120.3, and 110.7 ppm.

### 2-(2-Chlorophenyl)benzo\[*d*\]oxazole (**3n**)^[@ref21]^ {#sec4.4.13}

Crystal solid, yield 77%; 0.141 g, *R*~*f*~ = 0.7 (3% ethyl acetate/*n*-hexane); mp = 72--74 °C; lit., mp 72 °C MS: *m*/*z* 230 \[M + H\]^+^; ^1^H NMR (300 MHz, CDCl~3~): δ 8.15--8.12 (m, 1H), 7.86--7.83 (m, 1H), 7.61--7.53 (m, 2H), 7.44--7.36 (m, 4H); ^13^C NMR (75 MHz, CDCl~3~): δ 160.8, 150.4, 141.6, 133.3, 131.8, 131.7, 131.3, 126.8, 126.1, 125.5, 124.5, 120.4, and 110.6 ppm.

### 2-(2,3-Dichlorophenyl)benzo\[*d*\]oxazole (**3o**)^[@ref22]^ {#sec4.4.14}

Crystal solid, yield 45%; 0.0942 g, *R*~*f*~ = 0.6 (3% ethyl acetate/*n*-hexane); mp = 88--90 °C; lit., mp 90--92 °C MS: *m*/*z* 263 \[M + H\]^+^; ^1^H NMR (300 MHz, CDCl~3~): δ 8.01 (d, *J* = 7.8, 1H), 7.85--7.82 (m, 1H), 7.62--7.60 (m, 2H), 7.42--7.30 (m, 3H); ^13^C NMR (75 MHz, CDCl~3~): δ 160.2, 150.5, 141.4, 134.9, 132.6, 131.9, 130.0, 128.4, 127.2, 125.8, 124.7, 120.5, and 110.7 ppm; anal. calcd for C~13~H~7~Cl~2~NO: C, 59.12; H, 2.67; N, 5.30. Found: C, 59.37; H, 2.75; N, 5.21.

### 2-(4-Bromophenyl)benzo\[*d*\]oxazole (**3p**)^[@ref22]^ {#sec4.4.15}

White solid, yield 68%; 0.148 g, *R*~*f*~ = 0.6 (2% ethyl acetate/*n*-hexane); mp = 158--160 °C; lit., mp 158--159 °C MS: *m*/*z* 274 \[M + H\]^+^; ^1^H NMR (300 MHz, CDCl~3~): δ 8.11 (d, *J* = 8.4 Hz, 2H), 7.77--7.73 (m,1H), 7.65 (d, *J* = 8.4 Hz, 2H), 7.56--7.55 (m, 1H), 7.38--7.34 (m, 2H); ^13^C NMR (75 MHz, CDCl~3~): δ 162.1, 150.7, 142.0, 132.2, 129.0, 126.2, 126.1, 125.3, 124.7, 120.1, and 110.6 ppm.

### 2-(2-Bromophenyl)benzo\[*d*\]oxazole (**3r**)^[@ref22]^ {#sec4.4.16}

White solid, yield 71%; 0.155 g, *R*~*f*~ = 0.6 (2% ethyl acetate/*n*-hexane); mp = 52--54 °C; lit., mp 54--55 °C MS: *m*/*z* 274 \[M + H\]^+^; ^1^H NMR (300 MHz, CDCl~3~): δ 8.06 (d, *J* = 6.9 Hz, 1H), 7.85--7.82 (m, 1H), 7.75 (d, *J* = 7.8 Hz, 1H), 7.61--7.58 (m, 1H), 7.45--7.30 (m, 4H); ^13^C NMR (75 MHz, CDCl~3~): δ 161.4, 150.5, 141.5, 134.6, 132.0, 131.9, 128.3, 127.3, 125.4, 124.5, 121.8, 120.4, and 110.7 ppm.

### 2-(3-Bromophenyl)benzo\[*d*\]oxazole (**3s**)^[@ref22]^ {#sec4.4.17}

White solid, yield 63%; 0.137 g, *R*~*f*~ = 0.6 (2% ethyl acetate/*n*-hexane); mp = 128--130 °C; lit., mp 136--138 °C MS: *m*/*z* 274 \[M + H\]^+^; ^1^H NMR (500 MHz, CDCl~3~): δ 8.40--8.39 (m, 1H), 8.16--8.15 (m, 1H), 7.77--7.75 (m,1H), 7.64--7.62 (m, 1H), 7.57--7.55 (m, 1H), 7.38--7.34 (m, 3H); ^13^C NMR (125 MHz, CDCl~3~): δ 161.5, 150.8, 141.9, 134.4, 130.5, 129.1, 126.1, 125.6, 124.8, 123.0, 120.3, and 110.7 ppm.

### 2-(4-Chlorophenyl)-1-(*p*-tolyl)ethanone (**4**) {#sec4.4.18}

White solid, yield 96%; *R*~*f*~ = 0.6 (1% ethyl acetate/*n*-hexane); mp = 108--110 °C; lit., mp 113 °C MS: *m*/*z* 245 \[M + H\]^+^; ^1^H NMR (300 MHz, CDCl~3~): δ 7.88 (d, *J* = 8.1 Hz, 2H), 7.27--7.15 (m, 6H), 4.20 (s, 2H), 2.38 (s, 3H); ^13^C NMR (75 MHz, CDCl~3~): δ 196.6, 144.1, 133.8, 133.1, 130.8, 129.3, 128.6, 128.5, 44.4, and 21.5 ppm.

The Supporting Information is available free of charge on the [ACS Publications website](http://pubs.acs.org) at DOI: [10.1021/acsomega.7b00965](http://pubs.acs.org/doi/abs/10.1021/acsomega.7b00965).Typical experimental procedure and characterization data for acylbenzotriazoles and benzoxazoles, copies of ^1^H and ^13^C NMR spectra for all of the developed compounds, and 19F NMR spectra of fluorinated compounds ([PDF](http://pubs.acs.org/doi/suppl/10.1021/acsomega.7b00965/suppl_file/ao7b00965_si_001.pdf))
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